Oncos Therapeutics nominated the Nordic Star Finland by SwedenBIO

HELSINKI, Finland 15 October 2013 - Oncos Therapeutics Ltd was today nominated the Nordic Star Finland by SwedenBIO . This nomination was announced at the international business meeting Nordic Life Science Days in Stockholm, Sweden. According to the meeting organizers, the nomination highlights a shining example in the life science industry.

"We are naturally very honored by this nomination, which recognizes our great progress in all relevant areas - Clinical Development, CMC, and Clinical Science", says Dr. Antti Vuolanto, VP Production and Co-founder of Oncos.

About Nordic Life Science Days

Nordic Life Science Days brings together major European stakeholders, investors, decision makers and business developers. As a worldwide leading place for innovation and investments in the bio-economy, the Nordic region invites stakeholders to connect, network and partner at the meeting. For more information about the event please see http://www.nlsdays.com/.

About Oncos Therapeutics

Oncos Therapeutics Ltd is a privately owned, clinical-stage biotechnology company focused on the development and commercialization of targeted oncolytic immunotherapy products for solid tumors. The company's lead investor is HealthCap, one of the largest specialized providers of venture capital within life sciences in Europe. Oncos is headquartered in Helsinki, Finland and has an office in Switzerland. For more information about Oncos, please visit www.oncos.com.